Scott Lieberman
Internal Medicine · Franklin, TNNPI 1871644781
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,189 and has fallen 99.4% since, to $13 in 2022.
Across 173 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$410
- Pfizer$362
- GSK$335
- Lilly USA, LLC$286
- Novo Nordisk$276
- Boehringer Ingelheim$189
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,96197%
- Education$883%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $410 |
| Pfizer | 21 | $362 |
| GSK | 6 | $335 |
| Lilly USA, LLC | 18 | $286 |
| Novo Nordisk | 20 | $276 |
| Boehringer Ingelheim | 15 | $189 |
| Merck | 17 | $157 |
| Astellas Pharma US Inc | 5 | $142 |
| Johnson & Johnson | 9 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $123 |
| Kowa Pharmaceuticals America, Inc. | 8 | $115 |
| Biohaven Pharmaceuticals, Inc. | 1 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $78 |
| AbbVie(2 entities) | 3 | $52 |
| Amarin Pharma, Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| IBSA Pharma Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $24 |
| Eisai Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Novartis | 1 | $17 |
| Shire North American Group Inc | 1 | $17 |
| Amgen | 1 | $17 |
| Abbott | 1 | $13 |
| Nalpropion Pharmaceuticals LLC | 1 | $12 |
| Insmed, Inc. | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$226
- FASENRA$117
- EUCRISA$107
- NURTEC ODT$102
How this compares
$3,050 in reported general payments places this provider in the 80th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Franklin
- Devin ShermanFranklin$191K
- John AndersonNashville$1.5M
- Tracie WalkerJackson$488K
- Nathan TrenthamEtowah$404K
- Dennis DeruelleKnoxville$263K
- Lewis HagoodKnoxville$143K
- Temidayo AbeNashville$113K
- Kenya KozawaSweetwater$86K
- Wayne RileyNashville$86K
- Maighan SeagroveChattanooga$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.